Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05796505 · ClinicalTrials.gov registry record · NA

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

A NA study of COVID-19, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
37,122
Enrollment target
1
Study location

NCT05796505 is a NA study of COVID-19 that is actively recruiting participants, run by Yale University. The registered enrollment target is 37,122 participants, below the 55,032-participant average among 203 other COVID-19 trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05796505, a NA study of COVID-19, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
37,122 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness of these interventions through rapid cycle, cluster randomized trials in the Pennsylvania prison system.

Conditions Studied

Interventions

  • BEHAVIORAL ADVANCE Steering Committee interventions

Study Locations (1)

Pennsylvania

  • Pennsylvannia Department of Corrections - Schwenksville

Trial Details

FieldValue
Enrollment Target 37,122 participants
Start Date 2024-07-23
Est. Completion 2026-12-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT05796505

The ClinicalTrials.gov registry entry for NCT05796505 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 37,122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,032-participant average among 203 other COVID-19 trials with a reported enrollment target (33% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which ADVANCE Steering Committee interventions is the first listed.

NCT05796505 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05796505 about?

NCT05796505 is a clinical study titled "Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement". The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness...

What is the current status of trial NCT05796505?

This trial is currently recruiting. It is a NA study. The enrollment target is 37,122 participants. The study started on 2024-07-23. Estimated completion is 2026-12-31.

What conditions does trial NCT05796505 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05796505?

The interventions under investigation include: ADVANCE Steering Committee interventions (BEHAVIORAL).

Who is sponsoring clinical trial NCT05796505?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05796505 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.